Farmacia italiana online: acquisto cialis in Italia e Roma senza ricetta.

Arbeiten aus dem pathologischen institut 1999

Publikationen aus dem Pathologischen Institut
der Universität Würzburg in 1999
Avots, A., Buttmann, M., Chupvilo, S., Escher, C., Smola, U., Bannister, A.J., Rapp, U.R., Kouzarides, T., Serfling, E. CBP/p300 integrates Raf/Rac-signalling pathways in the transcriptional induction of NF-Atc during T cell activation Immunity 10: 515-524 (1999) Chirmule, N., Avots, A., LakshmiTamma, S.M., Pahwa, S., Serfling, E. CD4-mediated signals induce T cell dysfunction in vivo J. Immunol. 163: 644-649 (1999) Bannert, N., Avots, A., Baier, M., Serfling, E., Kurth, R. GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the interleukin 16 promoter in T lymphocytes Proc. Natl. Acad. Sci. USA 96: 1541-1546 (1999) Chupvilo, S., Zimmer, M., Kerstan, A., Glöckner, J., Avots, A., Escher, C., Fischer, C., Inashkina, I., Jankevics, E., Berberich-Siebelt, F., Schmitt, E., Serfling, E. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells Immunity 10: 261-269 (1999) Chupvilo, S., Avots, A., Berberich-Siebelt, F., Glöckner, J., Fischer, C., Kerstan, A., Escher, C., Inashkina, I., Hlubek, F., Jankevics, E., Brabletz, T., Serfling, E. Multiple NF-Atc isoforms with individual transcriptional properties are synthesized in T lymphocytes J. Immunol. 162: 7294-7301 (1999) Wagner, S., Czub, S., Greif, M., Vince, H., Süss, N., Kerjkau, S., Rieckmann, P., Roggendorf, W., Roosen, K., Tonn, J.-C. Microglial/macrophage expression of interleukin 10 in human glioblastomas Int. J. Cancer 82: 12-16 (1999) Sebekova, K., Dämmrich, J., Krivosikova, Z., Heidland, A. The effect of the oral protease administration in the rat remnant kidney model Res. Exp. Med. 199: 177-188 (1999) Eck, M., Greiner, A., Schmaußer, B., Eck, H., Kolve, M., Fischbach, W., Strecker, P., Müller-Hermelink, H.K. Evaluation of Helicobacter pylori in gastric MALT-type lymphoma: differences between histologic and serologic diagnosis Mod. Pathol. 12: 1148-1151 (1999) Hoppe, H., Gasser, M., Gassel, A.M., Vowinkel, T., Timmermann, W., Otto, C., Tykal, K., Thiede, A. Noninvasive videomicroscopic monitoring of rat small-bowel rejection Microsurgery 19: 89-94 (1999) Al-Taie, O.H., Mörk, H., Gassel, A.M., Wilhelm, M., Weissbrich, B., Scheurlen, M. Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature Ann. Hematol. 78: 247-249 (1999) Dinkel, H.-P., Clees, M., Gassel, A.M. Role of sonography in detecting recurrence in adenoid cystic carcinoma of the breast Am. J. Roentgenol. 173: 497-498 (1999) Timmermann, W., Hoppe, H., Otto, C., Gasser, M., Vowinkel, T., Gassel, A.M., Meyer, D., Gassel, H.-J., Ulrichs, K., Thiede, A. Videomicroscopic imaging of graft mucosa for monitoring immunosuppressive therapy after small intestinal transplantation in rats Publikationen aus der Pathologie Würzburg in 1999 Transplantation 67: 1555-1561 (1999) Gattenlöhner, S., Dockhorn-Dworniczak, B., Leuschner, I., Vincent, A., Müller-Hermelink, H.K., Marx, A. A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues J. Mol. Diag. 1: 23-31 (1999) Gattenlöhner, S., Müller-Hermelink, H.K., Marx, A. Transcription of the nude gene (WHN) in human normal organs and mediastinal and pulmonary tumors Pathol. Res. Pract. 195: 571-574 (1999) Bitsch, A., Deubelbeiss, C., Greiner, A. c-fos gene expression in rat liver is induced by phenobarbital Cancer Lett. 135: 215-222 (1999) Kolve, M., Fischbach, W., Greiner, A., Wilms, K. Differences in endoscopic and clinicopathological features of primary and secondary gastric non-Hodgkin’s lymphoma Gastrointest. Endosc. 49: 307-315 (1999) Körber, C., Schmutzler, C., Rendl, J., Köhrle, J., Griesser, H., Simon, D., Reiners, C. Increased I-131 uptake in local recurrence and distant metastases after second treatment with retinoic acid Clin. Nucl. Med. 24: 849-851 (1999) Haedicke, W., Greiner, A., Seeberger, H., Müller-Hermelink, H.K. Oligoclonal expansions of T-cell repertoire in gastric mucosa associated lymphoid tissue type B-cell lymphoma and adjacent gastritis Diagn. Mol. Pathol. 8: 138-144 (1999) Hensel, F., Hermann, R., Schubert, C., Abé, N., Schmidt, C., Franke, A., Shevchenko, A., Mann, M., Müller-Hermelink, H.K., Vollmers, H.P. Characterization of glycosylphosphatidylinositol-linked molecule CD55/decay-accelerating factor as the receptor for antibody SC-1 induced apoptosis Cancer Res. 59: 5299-5306 (1999) Hensel, F., Knörr, C., Hermann, R., Krenn, V., Müller-Hermelink, H.K., Vollmers, H.P. Mitogenic autoantibodies in Helicobacter pylori-associated stomach cancerogenesis Int. J. Cancer 81: 229-235(1999) Vince, G.H., Wagner, S., Pietsch, T., Klein, R., Goldbrenner, R.H., Roosen, K., Tonn, J.C. Heterogenous regional expression patterns of matrix metalloproteinase in human malignant gliomas Int. J. Dev. Neurosci 17 : 437-445 (1999) Klein, R., Müllges, W., Bendszus, M., Woydt, M., Kreipe, H., Roggendorf, W. Primary intracerebral Hodgkin's disease Am. J. Surg. Pathol. 34: 477-481 (1999) Anetseder, M., Pohl, F., Klein, R., Müller, R., Hoyer, A., Horbaschek, H., Roggendorf, W., Hartung, E., Roewer, N. Sind morphologische Veränderungen im Skelettmuskel von Patienten mit Maligner Hyperthermie diagnostisch verwertbar? Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 34: 626-633 (1999) Knörr, C., Amrhen, C., Seeberger, H., Rosenwald, A., Stilgenbauer, S., Ott, G., Müller-Hermelink, H.K., Greiner, A. Expression of costimulatory molecules in low-grade mucosa-associated lymphoid tissue-type lymphomas in vivo Am. J. Pathol. 155: 2019-2027 (1999) Hauser, W., Knobeloch, K.-P., Eigenthaler, M., Gambaryan, S., Krenn, V., Geiger, J., Galzova, M., Rohde, E., Horak, I., Walter, U., Zimmer, M. Publikationen aus der Pathologie Würzburg in 1999 Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice Proc. Natl. Acad. Sci. 96: 8120-8125 (1999) Krenn, V., König, A., Hensel, F., Berek, C., Souto Carneiro, M.M., Haedicke, W., Wang, Y.K., Vollmers, H.-P., Müller-Hermelink, H.K. Molecular analysis of rheumatoid factor (RF)-negative B cell hybridomas from rheumatoid synovial ttissue: evidence foran antigen-induced stimulation with selection of high mutated IgVH and low mutated IgVL /λ genes Clin. Exp. Immunol. 115: 168-175 (1999) Krenn, V., Hensel, F., Kim, H.J., Souto Carneiro, M.M., Starostik, P., Ristow, G., König, A., Vollmers, H.P., Müller-Hermelink, H.K. Molecular IgV (H) analysis demonstrates highly somatic mutated B cells in synovialtitis of osteoarthritis: a degenerative disease is associated with a specific, not locally generated immune response Lab. Invest. 79: 1377-1384 (1999) Schultz, H., Krenn, V., Tony, H.-P. Oligioarthritis mediated by tumor-specific T lymphocytes in renal-cell carcinoma N. Engl. J. Med. 341: 290-291 (1999) Kim, H.-J., Krenn, V., Steinhauser, G., Berek, C. Plasma cell development in synovial germinal centers in patients with rheumatoid arthritis and reactive arthritis J. Immunol. 162: 3053-3062 (1999) Sack, U., Günther, A., Pfeiffer, R., Genest, M., Kinne, J., Biskop, M., Kämpfer, I., Krenn, V., Emmrich, F., Lehmann, J. Systemic characteristics of chronic arthritis induced by transfer of human rheumatoid synovial membrane into SCID mice J. Autoimmun. 13: 335-346 (1999) Müller, J., Marx, A., Sack, S., Song, Y.-H., Madelkow, E. The structure of the nucleotide-binding site of kinesin Biol. Chem. 380: 981-992 (1999) Yoneda, S., Marx, A., Heimann, S., Shirakusa, T., Kikuchi, M., Müller-Hermelink, H.K. Low-grade metaplastic carcinoma of the thymus Histopathology 35: 19-30 (1999) Yoneda, S., Marx, A., Müller-Hermelink, H.K. Low-grade metaplastic carcinoma of the thymus Pathol. Res. Pract. 195: 555-563 (1999) Marx, A., Müller-Hermelink, H.K. Thymoma and thymic carcinoma Am. J. Surg. Pathol. 23: 739-742 (1999) Engel, P., Marx, A. Thymic tumours in Denmark Pathol. Res. Pract. 195: 565-570 (1999) Tonn, J.C., Kerkau, S., Hanke, A., Bouterfa, H., Müller, J.G., Wagner, S., Vince, G.H., Roosen, K. Effect of the synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of malignant gliomas in vitro Int. J. Cancer 80: 764-772 (1999) Christl, S.U., Müller, J.G. Fatty liver in adult celiac disease DMW 124: 691-694 (1999) Neben, K., Heidbreder, M., Müller, J., Marxer, A., Petry, H., Didier, A., Schimpl, A., Hünig, T., Kerkau, T. Publikationen aus der Pathologie Würzburg in 1999 Impaired thymopoietic potential of immature CD3(-)CD4(+)CD8(-) T cell precursors from SIV-infected rhesus monkeys Int. Immunol. 11: 1509-1518 (1999) Jaffe, E.S., Diebold, J., Harris, N.L., Müller-Hermelink, H.K., Flandrin, G., Vardiman, J.W. Burkitt’s lymphoma: a single disease with multiple variants. The world Health Organization classification og neoplastic diseases of the hematopoietic and lymphoid tissues Blood 93: 1124 (1999) Girschik, H.J., Huppertz, H.-I., Harmsen. D., Krauspe, R., Müller-Hermelink, H.K., Papadopoulos, T. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing Hum. Pathol. 30: 59-65 (1999) Nathwani, B.N., Anderson, J.R., Armitage, J.O., Cavalli, F., Diebold, J., Drachenberg, M.R., Harris, N.L., Mac Lennan, K.A., Müller-Hermelink, H.K., Ullrich, F.A., Weisenburger, D.D. Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin’s Lymphoma Classification Project Hum. Pathol. 30: 263-268 (1999) Pilozzi, E., Müller-Hermelink, H.K., Falini, B., de Wolf-Peeters, C., Fidler, C., Gatter, K., Wainscoat, J. Gene rearrangements in T-cell lymphoblastic lymphoma J. Pathol. 188: 267-270 (1999) Nathwani, B.N., Anderson, J.R., Armitage, J.O., Cavalli, F., Diebold, J., Drachenberg, M.R., Harris, N.L., MacLennan, K.A., Müller-Hermelink, H.K., Ullrich, F.A., and Weisenburger, D.D. for the Non-Hodgkin’s Lymphoma Classification Project Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types J. Clin. Oncol. 17: 2486-2492 (1999) Müller-Hermelink, H.K., Marx, A. Pathological aspects of malignant and benign thymic disorders Ann. Med. 31 Suppl. 2: 5-14 (1999) Jaffe, E.S., Müller-Hermelink, H.K. Relationship between Hodgkin’s disease and Non-Hodgkin’s lymphomas In: Hodgkin’s disease. Ed. by P.M. Mauch et al. Philadelphia: Lippincott Williams and Wilkins, 1999. 181-193 Harris, N.L., Müller-Hermelink, H.K. Thymoma classification. A siren’s song of simplicity Am. J. Clin. Pathol. 112: 308-310 1999) Müller-Hermelink, H.K., Marx, A. Thymomas and thymic cancers In: Human cell culture. Vol. II. Cancer cell lines part 2. Ed. by John R.W. Masters. Dordrecht: Kluwer Academic Publishers, 1999. 149-155 Müller-Hermelink, H.K. Weltweiter Konsens: Von der KIEL-Klassifikation über die REAL-Klassifikation zur WHO-Klassifikation Verh, Dtsch. Ges. Path. 83: 155-161 (1999) Jaffe, E.S., Harris, N.L., Diebold, J., Müller-Hermelink, H.K. World Health Oganization classification of neoplastic diseases of the hematopoietic and lymphoid tissue Am. J. Clin. Pathol. 111 (Suppl. 1): S8-S12 81999) Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Müller-Hermelink, H.K., Vardiman, J., Lister, T.A., Bloomfield, C.D. World Health Organization Classification of neoplastic diseases of the henatopoietic and lymphoid tissues: report of the clinical advisory committee meeting – Airline House, Virgina, November 1997 J. Clin. Oncol. 17: 3835-3849 (1999) Publikationen aus der Pathologie Würzburg in 1999 Kunz, M., Hartmann, A., Flory, E., Toksoy, A., Koczan, D., Thiesen, H.J., Mukaida, N., Neumann, M., Rapp, U.R., Bröcker, E.B. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma Am. J. Pathol. 155: 753-763 (1999) Pelzer, T., Schumann, M., Neumann, M., deJager, T., Stimpel, M., Serfling, E., Neyses, L. 17ß-Estradiol prevents programmed cell death in cardiac myocytes Biochem. Biophys. Res. Comm. 268: 192-299 (2000) Ott, G., Greiner, A. Maligne Non-Hodgkin-Lymphome vom MALT-Typ: Fortschritte in der Bioptischen Diagnostik und der Pathogenese Verh. Dtsch. Ges. Path. 83: 79-89 (1999) Holz, F.G., Boehmer, H. v., Mechtersheimer, G., Ott, G., Völcker, H.E. Uveal non-Hodgkin’s lymphoma with epibulbar extension simulating choroidal effusion syndrome Retina 19: 343-346 (1999) Stilgenbauer, S., Winkler, D., Ott, G., Schaffner, C., Leupolt, E., Bentz, M., Möller, P., Müller-Hermelink, H.K., James, M.R., Lichter, P., Döhner, H. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma Blood 94: 32 62-3264 (1999) Heimburg. S., Oehler, M.K., Papadopoulos, T., Caffier, H., Kristen, P., Dietl, J. Prognostic relevance of the endothelial marker CD34 in ovarian cancer Anticancer Res. 19: 2527-2529 (1999) Pulford, K., Falini, B., Cordell, J., Rosenwald, A., Ott, G., Müller-Hermelink, H.K., MacLennan, K.A., Lamant, L., Carbone, A., Campo, E., Mason, D.Y. Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma Am. J. Pathol. 154: 1657-1663 (1999) Rosenwald, A., Ott, G., Krumdiek, A.K., Dreyling, M.H., Katzenberger, T., Kalla, J., Roth. S., Ott, M.M., Müller-Hermelink, H.K. A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral T-cell lymphomas? Genes Chromosom. Cancer 26: 210-214 (1999) Rosenwald, A., Ott, G., Stilgenbauer, S., Kalla, J., Bredt, M., Katzenberger, T., Greiner, A., Ott, M.M., Gawin, B., Döhner, H., Müller-Hermelink, H.K. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas Am. J. Pathol. 155: 1817-1821 (1999) Rosenwald, A., Ott, G., Katzenberger, T., Siebert, R., Kalla, J., Kuse, R., Ott, M., Müller-Hermelink, H.K., Schlegelberger, B. Jumping translocation of 1q as the sole aberration in a case of follicular lymphoma Cancer Genet. Cytogenet. 108: 53-56 (1999) Rosenwald, A., Ott, G., Pulford, K., Katzenberger, T., Kühl, J., Kalla, J., Ott, M.M., Mason, D.Y., Müller-Hermelink, H.K. T(1;2)(q21;p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma Blood 94: 362-364 (1999) Schultz, A., Hoffacker, V., Wilisch, A., Nix, W., Gold, R., Schalke, B., Tzartos, S., Müller-Hermelink, H.K., Marx, A. Neurofilament is an autoantigenic determinant in myasthenia gravis Ann. Neurol. 46: 167-175 (1999) Publikationen aus der Pathologie Würzburg in 1999 Rose, C., Starostik, P., Bröcker, E.B. Infection with parapoxvirus induces CD30-positive cutaneous infiltrates in humans J. Cutan. Pathol. 26: 520-522 (1999) Ströbel, P., Nanan, R., Gattenlöhner, S., Müller-Deubert, S., Müller-Hermelink, H.K., Kreth, H.W., Marx, A. Reversible monoclonal lymphadenopathy in sutoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency Am. J. Surg. Pathol. 23: 829-837 (1999) Timmermann, W., Vollmers, H.P. Immuntherapie: ein Antikörper gegen Magenkrebs Blick 1: 81-83 (1999) Wilisch, A., Gutsche, S., Hoffacker, V., Schultz, A., Tzartos, S., Nix., W., Schalke, B., Schneider, C., Müller-Hermelink, H.K., Marx, A. Association of acetylcholine receptor alpha-subunit gene expression in mixed thymoma with myasthenia gravis Neurology 52: 1460-1466 (1999) Publikationen aus der Pathologie Würzburg in 1999

Source: http://www.pathologie.uni-wuerzburg.de/fileadmin/03240000/Literaturlisten/Publikationsliste_1999.pdf

Slide

Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors Learning Objectives After reading and reviewing this material, the participant should be better able to:• Identify symptoms of androgen deficiency in pre and post menopausal breast cancer survivors• Recognize the potential role of subcutaneous testosterone-anastrozole implant therapy in safely tr

History new general patient (42

©2003. Sparrow Systems, Inc. Patent Pending. General Patient History Location of Worst Problem (if you are seeing us for more than 1 problem)Please describe your current problem? (If you are seeing the doctor for multiple problems, answer for the most severe)New Injury or problem (less than 3 months duration)Subacute problem (began slowly with no identifiable cause and progressively worsene

Copyright © 2010-2014 Pdf Pills Composition